TSE:4543Medical Equipment
Assessing Terumo (TSE:4543) Valuation After New Cell And Gene Therapy Blueprint Announcement
Why Terumo’s new cell and gene therapy blueprint matters for shareholders
Terumo (TSE:4543) is drawing attention after its Blood and Cell Technologies unit introduced a C> Ecosystem Blueprint to support cell and gene therapy developers in Asia Pacific, focusing on workflows, capabilities, and collaborative partnerships.
See our latest analysis for Terumo.
Terumo’s 1 day share price return of 4.33% to ¥2,061 comes after a period of weaker momentum, with a 90 day share price return of 13.02%...